Akihiro Tsuda Selected Research

Akihiro Tsuda Research Topics

Disease

6	Proteinuria 12/2022 - 01/2015
5	Insulin Resistance 01/2022 - 01/2014
5	Chronic Renal Insufficiency 01/2021 - 01/2015
4	Diabetes Mellitus 01/2021 - 01/2015
4	Type 2 Diabetes Mellitus (MODY) 09/2020 - 01/2014
3	Autosomal Dominant Polycystic Kidney (ADPKD) 11/2021 - 08/2018
2	Edema (Dropsy) 10/2022 - 03/2021
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 10/2022 - 01/2018
2	Hyperuricemia 01/2022 - 12/2021
2	Dyslipidemias (Dyslipidemia) 01/2021 - 06/2018
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 06/2018
2	Glomerulonephritis 01/2017 - 07/2014
2	Delirium 01/2014 - 02/2013
1	IGA Glomerulonephritis (IGA Nephropathy) 12/2022
1	Crohn Disease (Crohn's Disease) 12/2022
1	Infections 11/2022
1	Nutrition Disorders (Nutritional Disorders) 11/2022
1	COVID-19 01/2022
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2022
1	Erythema elevatum diutinum 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Heart Failure 12/2021
1	Body Weight (Weight, Body) 03/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Hypercholesterolemia 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Vascular Calcification 09/2020
1	Obesity 01/2019
1	Sarcopenia 01/2019
1	Anemia 11/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2018
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 11/2018
1	Albuminuria 11/2018
1	Glucose Intolerance 11/2018
1	Hyperkalemia 05/2018
1	Cushing Syndrome 05/2018
1	Pituitary ACTH Hypersecretion 05/2018
1	Joint Diseases (Joint Disease) 03/2016
1	Arteriosclerosis 01/2015
1	Membranous Glomerulonephritis (Membranous Nephropathy) 09/2014
1	Immunoglobulin G4-Related Disease 07/2014
1	Vascular System Injuries 01/2014

Drug/Important Bio-Agent (IBA)

4	CreatinineIBA 10/2022 - 07/2013
3	Proteins (Proteins, Gene)FDA Link 11/2022 - 03/2021
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 07/2014
3	Xanthine DehydrogenaseIBA 01/2022 - 01/2019
3	Uric Acid (Urate)IBA 12/2021 - 01/2019
2	oxidized low density lipoproteinIBA 01/2021 - 06/2018
2	XanthineIBA 01/2021 - 01/2019
2	LDL CholesterolIBA 01/2021 - 06/2018
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 01/2018
2	Tolvaptan FDA Link 01/2020 - 08/2018
2	AdiponectinIBA 01/2020 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 11/2018 - 03/2015
2	Glucose (Dextrose)FDA LinkGeneric 11/2018 - 11/2017
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2015
2	ramelteon (Rozerem)FDA Link 01/2014 - 02/2013
1	Adalimumab (Humira)FDA Link 12/2022
1	SteroidsIBA 12/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Febuxostat FDA Link 12/2021
1	Allopurinol (Remid)FDA LinkGeneric 12/2021
1	Calcium-Sensing ReceptorsIBA 11/2021
1	Cinacalcet (Sensipar)FDA Link 11/2021
1	alpha-2-HS-GlycoproteinIBA 01/2021
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	ZincIBA 09/2020
1	Vasopressins (Vasopressin)IBA 01/2020
1	MineralsIBA 11/2018
1	hydroxide ionIBA 11/2018
1	Serum AlbuminIBA 11/2018
1	1,25-dihydroxyvitamin DIBA 11/2018
1	Fibroblast Growth Factor-23IBA 11/2018
1	Ferritins (Ferritin)IBA 11/2018
1	mercaptoalbuminIBA 11/2018
1	AlbuminsIBA 11/2018
1	ReninIBA 05/2018
1	MineralocorticoidsIBA 05/2018
1	GlucocorticoidsIBA 05/2018
1	FludrocortisoneIBA 05/2018
1	dapagliflozinIBA 05/2018
1	AldosteroneIBA 05/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2018
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2018
1	IronIBA 01/2018
1	GalliumIBA 01/2017
1	C-Reactive ProteinIBA 03/2016
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2014
1	entecavir FDA Link 09/2014
1	MelatoninIBA 01/2014

Therapy/Procedure

5	Therapeutics 01/2022 - 07/2014
3	Renal Dialysis (Hemodialysis) 11/2022 - 01/2019
3	Glycemic Control 01/2021 - 01/2014
3	Blood Component Removal (Apheresis) 01/2021 - 01/2018
1	Adrenalectomy 05/2018
1	Transplantation 01/2015